跳至主要内容
临床试验/NCT01384864
NCT01384864已完成早期 1 期

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Anandasabapathy, Sharmila, M.D.1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
to determine whether tissue is neoplastic or non-neoplastic

研究概览

简要总结

The overall objective of this pilot study is to determine whether multispectral imaging increases the diagnostic accuracy of the current standard of high-definition white-light endoscopy for the detection of Barrett's-associated neoplasia (high grade dysplasia or cancer). The investigators goal is to develop a multispectral endoscopic platform that can be used to survey a large surface area and, potentially, serve as a 'red flag' for microendoscopic imaging of small areas. The goal of this pilot study is to preliminarily determine the accuracy of these modalities during the endoscopic surveillance of Barrett's esophagus.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • known or suspected barrett's esophagus with intraepithelial neoplasia(HGD/cancer)

排除标准

  • 未提供

研究组 & 干预措施

treatment

Experimental

fluorescent imaging with proflavine

干预措施: proflavine (Drug)

结局指标

主要结局

to determine whether tissue is neoplastic or non-neoplastic

时间窗: 1 day

次要结局

未报告次要终点

研究者

发起方
Anandasabapathy, Sharmila, M.D.
申办方类型
Indiv
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验